Axcelis announces timing for Q3 2026 results and conference call
Results release on November 5, 2026. Webcast at 8:30 a.m. ET with replay available for 30 days.
See the latest news and media coverage for Axcelis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Ion implantation equipment manufacturer for semiconductors
axcelis.comLast updated
In short: Axcelis secured merger approval, named a new CFO, and invested in Korean capacity amid steady quarterly results.
Results release on November 5, 2026. Webcast at 8:30 a.m. ET with replay available for 30 days.
Non-GAAP diluted EPS was $1.06 and GAAP diluted EPS was $0.75. The company issued Q3 2026 guidance of $230M revenue.
Results will be released before market open on August 6, 2026, followed by a webcast at 8:30 a.m. ET.
The company noted strength in its CS&I business and momentum in the Memory market
Axcelis shares fell 22.4% in a month as recovering bookings and demand collide with weaker margins, backlog pressure and heavy China exposure.
Beverly, Mass., Sept. 8, 2026 /PRNewswire/-- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of ion implantation solutions for the semiconductor industry, announced plans to build a new ion implantation equipment manufacturing facility in Hwaseong, Gyeonggi Province, South Korea, and invest $35 million in its global manufacturing infrastructure...
In February, Axcelis reported a near 18% fall in 2025 sales to $839 million; this resulted in some deleveraging. GAAP ...
Research Analysts’ downgrades for Friday, August 7th: Axcelis Technologies (NASDAQ:ACLS) was downgraded by analysts at Craig Hallum from a buy rating to a hold rating...
Track Axcelis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Axcelis and other trending companies.